Literature DB >> 1137370

Activity of cefazolin against dense populations of enterobacteria.

D Greenwood, C H Chan-Teoh, F O'Grady.   

Abstract

The in vitro activity of cefazolin was assessed by continuous turbidimetric monitoring of cultures of gram-negative bacilli and the results were compared with those previously obtained with other beta-lactam agents using the same strains and methods. Cefazolin was found to induce rapid lysis of ampicillin-susceptible and -resistant strains of Escherichia coli at a lower concentration than any other beta-lactam agent tested; its stability to beta-lactamase, as judged by regrowth studies, was generally considerably greater than that of other antibiotics of this group. Tested against 103 ampicillin-resistant enterobacteria, cefazolin was found to be more active than cephalothin against E. coli, but no systematic increase in susceptibility to cefazolin was seen with other species. A study of cefazolin in an in vitro model which simulates the hydrokinetic features of the urinary bladder showed it to be as active as ampicillin against ampicillin-susceptible E. coli and as active as cephalothin against ampicillin-resistant E. coli.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137370      PMCID: PMC429102          DOI: 10.1128/AAC.7.2.191

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1974-06

2.  The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1972-10

3.  Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder.

Authors:  F O'Grady; I P Mackintosh; D Greenwood; B W Watson
Journal:  Br J Exp Pathol       Date:  1973-06

4.  Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

5.  Cefazolin therapy of urinary tract infections.

Authors:  C E Cox
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  A twelve channel bacterial growth monitoring system.

Authors:  I P Mackintosh; F O'Grady; D Greenwood; B W Watson; T C Crichton; R Piper; A Ferrer
Journal:  Biomed Eng       Date:  1973-12

7.  Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.

Authors:  N H Steigbigel; C E McCall; C W Reed; M Finland
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

8.  Experience with cefazolin: an overall summary of pharmacologic and clinical trials in man.

Authors:  J A Gold; J J McKee; D S Ziv
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

9.  Pharmacokinetics of cefazolin compared with four other cephalosporins.

Authors:  W M Kirby; C Regamey
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

10.  Use and control of cephalosporins.

Authors:  S Eykyn
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

  10 in total
  2 in total

1.  Dual-action cephalosporin utilizing a novel therapeutic principle.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

2.  Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin.

Authors:  C S Goodwin; J P Hill
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.